The brain can be harmed by abnormal protein buildup, traumatic injury, and progressive neuron loss. Three recent studies explore different conditions but share a common theme: protecting the brain may depend on strengthening natural defenses and limiting damaging biological responses. One study found that DNAJB6b can suppress harmful tau fibrils linked to Alzheimer’s disease. Another showed that blocking harmful IL-6 signaling after traumatic brain injury improved learning and memory in male mice.
A third study found that ginsenosides from American ginseng protected dopamine-producing neurons and improved movement in a zebrafish model of Parkinson’s disease, potentially by reducing TNF-α driven inflammation. Together, these findings highlight complementary strategies for neuroprotection, from controlling protein aggregation to regulating inflammation. While still experimental, they broaden our understanding of how preserving brain function may require targeting the processes that worsen damage over time.
1. Human chaperone DNAJB6b suppresses tau fibril formation through co-aggregation
Scientists found that DNAJB6b, a protective protein naturally produced by human cells, can strongly suppress the formation of tau fibrils, the abnormal protein structures associated with Alzheimer’s disease. Instead of binding normal tau, DNAJB6b appears to target early tau aggregates and mature fibrils, slowing their growth and increasing tau’s apparent solubility. The findings point to the cell’s own protein-quality-control system as a potential future therapeutic target for preventing or slowing harmful tau accumulation.
2. Peripheral and Central Administration of Soluble Glycoprotein 130 Improves Cognitive Outcomes Following Controlled Cortical Impact in Male Mice
Researchers found that a single dose of sgp130Fc, which selectively blocks harmful IL-6 trans-signaling, improved aspects of learning and memory after traumatic brain injury in male mice. The treatment did not significantly reduce lesion size, but it appeared to improve cognitive recovery and reduce some signs of inflammation, suggesting that selectively calming post-injury inflammation may support brain recovery.
3. Panax quinquefolius ginsenosides for neuroprotection in Parkinson’s disease via TNF-α inhibition
Ginsenosides from American ginseng (Panax quinquefolius) protected dopamine-producing neurons and improved movement in a zebrafish model of Parkinson’s disease. Researchers found the effects may involve suppressing TNF-α and other inflammatory pathways, suggesting these natural plant compounds could offer a promising avenue for further Parkinson’s research.
If you’d like to stay informed of the latest publications and breakthroughs in neuron regeneration, join our email newsletter to the right (or below on mobile). We send out weekly updates with the latest papers and studies, as well as podcast episodes with the people driving Neuroregenerative breakthroughs.
